Beyond Air Hosting Analyst Day Today, March 5, 2020 at 2:00 p.m. ET
Beyond Air, Inc. (XAIR)
Company Research
Source: GlobeNewswire
Announces new program targeting solid tumors with nitric oxide Secured a $25 million line of credit Timelines remain on track for PPHN, BRO and NTM programs GARDEN CITY, N.Y. and REHOVOT, Israel, March 05, 2020 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including, serious lung infections and pulmonary hypertension, and gaseous NO for the treatment of solid tumors, will host an analyst day in New York City today, March 5, 2020. Topics to be discussed this afternoon: COVID-19 LungFit™ potential impact Persistent Pulmonary Hypertension of the Newborn (PPHN) Premarket Approval (PMA) submission to FDA on track for the second quarter of calendar 2020Assessing option of marketing alone or out-licensing in the United States Bronchiolitis (BRO) Enrollment for third pilot study in Israel complete with data antic
Show less
Read more
Impact Snapshot
Event Time:
XAIR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XAIR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XAIR alerts
High impacting Beyond Air, Inc. news events
Weekly update
A roundup of the hottest topics
XAIR
News
- National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products [Yahoo! Finance]Yahoo! Finance
- Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy [Yahoo! Finance]Yahoo! Finance
- Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 TherapyGlobeNewswire
- Beyond Air Receives CE Mark in Europe for the LungFit® PH System [Yahoo! Finance]Yahoo! Finance
- Beyond Air Receives CE Mark in Europe for the LungFit® PH SystemGlobeNewswire
XAIR
Earnings
- 11/11/24 - Beat
XAIR
Sec Filings
- 12/20/24 - Form 8-K
- 12/13/24 - Form S-8
- 12/6/24 - Form 8-K
- XAIR's page on the SEC website